VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: A retrospective cohort study

4Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aim: The study objectives were to investigate the association between selected CYP2C9 and VKORC1 single nucleotide polymorphisms with serious bleeding or thrombotic risk, and to estimate mean daily maintenance dose of warfarin and international normalized ratio measurements among Blacks receiving warfarin anticoagulation. Methods: We conducted a retrospective cohort study among 230 Black adults receiving warfarin for a minimum of three consecutive months with a confirmed date of first dosage. Results: A lower mean daily maintenance dosage of warfarin was required to maintain an international normalized ratio measurement within the therapeutic range among Blacks with the VKORC1-1639G>A variant alleles ([G/A vs G/G, p = 0.02], [A/A vs G/A, p = 0.008] and [A/A vs G/G, p = 0.001]). Conclusion: Data indicated that VKORC1-1639A variant allele influenced warfarin daily maintenance dosage among our small, likely admixed Black patient population.

Cite

CITATION STYLE

APA

Mili, F. D., Allen, T., Wadell, P. W., Hooper, W. C., Staercke, C. D., Bean, C. J., … Wenger, N. K. (2018). VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: A retrospective cohort study. Future Cardiology, 14(1), 15–26. https://doi.org/10.2217/fca-2017-0025

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free